Quantcast

Latest Metformin Stories

2011-08-16 07:00:00

SAN FRANCISCO, Aug. 16, 2011 /PRNewswire/ -- Practice Fusion's Research Division released today the second annual Prescription Index of the 20 most commonly prescribed medications by specialty among physicians using the company's Electronic Medical Record (EMR) system. Topping the list are prescriptions for blood pressure (Lisinopril, Family Practice), cholesterol (Simvastatin, Internal Medicine), infection (Amoxicillin, Pediatrics) and depression (Trazodone, Psychiatry). Since the release...

2011-07-25 18:00:00

DEERFIELD, Ill. and OSAKA, Japan, July 25, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., resubmitted two New Drug Applications (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for alogliptin and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet. The FDA will review the NDA resubmissions within the...

2011-07-21 06:00:00

CARLSBAD, Calif., July 21, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B. ISIS-PTP1BRx is designed to increase the body's sensitivity to the natural hormone insulin, resulting in better glucose control for patients with type 2 diabetes. Because of its unique mechanism ISIS-PTP1BRx has the...

2011-06-30 01:31:53

PCOS is most common cause of infertility in women A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that early, prolonged treatment with the diabetes drug metformin may prevent or delay the development of polycystic ovary syndrome (PCOS) in adolescence. PCOS affects 7 to 10 percent of women of childbearing age and is the most common cause of infertility, affecting an estimated 5 to 6 million women in the United...

2011-06-29 18:00:44

Clinical studies confirm linagliptin's efficacy and tolerability in combination therapy with metformin Boehringer Ingelheim and Lilly today announced Phase III study results for linagliptin*, demonstrating improved glycemic control in adults with type 2 diabetes (T2D) whose blood glucose is not adequately controlled on current therapy. In one long-term study over two years evaluating linagliptin or glimepiride when added to metformin, linagliptin was effective at lowering blood glucose, as...

2011-06-29 09:52:00

GRAND RAPIDS, Mich., June 29, 2011 /PRNewswire/ -- Delivering a healthy dose of good news to Midwest families, Meijer announced today that its free pre-natal vitamins prescription program has filled its 1,000,000th prescription, at a cost savings of nearly $14 million to Midwest families. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/meijer/50770/ (Photo: http://photos.prnewswire.com/prnh/20110629/MM22967 ) The...

2011-06-27 17:30:00

MOUNTAIN VIEW, Calif., June 27, 2011 /PRNewswire/ -- ChemoCentryx, Inc. today announced that CCX140, the Company's novel, orally active CCR2 antagonist successfully met its primary endpoint of safety and tolerability and demonstrated clinical efficacy in a Phase II study in patients with type 2 diabetes on stable doses of metformin. These data were presented today in San Diego at the 71st Annual Scientific Session of the American Diabetes Association in an oral presentation entitled "Oral...

2011-06-27 14:14:13

New data presented at the American Diabetes Association 71st Scientific Sessions In a new post-hoc analysis based on the American Association of Clinical Endocrinologists (AACE/ACE) diabetes algorithm presented at the American Diabetes Association (ADA) 71st Annual Scientific Sessions, significantly more patients with type 2 diabetes treated with JANUMET® (sitagliptin/metformin HCl) tablets achieved blood sugar goals after 18 weeks compared to metformin as initial therapy....


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related